Litigation Details for HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
✉ Email this page to a colleague
HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-07-02 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | Plaintiff | Referred To | Cathy L. Waldor |
Patents | 8,067,033 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC.
Details for HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-05-05 | 83 | Opinion | counterclaims relating to U.S. Patent No. 8,067,033 (“the ’033 patent”) pending resolution of Horizon…litigation regarding six patents related to the drug Duexis®. Plaintiff holds the patents and Defendant Teva…GRANTED; that all proceedings relating to the 033 patent in this case are hereby STAYED pending resolution…litigated a similar case, involving the same six patents and an ANDA to make a generic version of Duexis…inter alia: 1) claims 1, 8, 11, and 14 of the ’033 patent are invalid as obvious and not infringed; and | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |